RUNX1 and acute myeloid leukemia: These findings were further validated by results showing that miR‐383 levels were twofold higher in AML1‐ETO+ than AML1‐ETO− AML blasts (Fig 4F) in an additional cohort of 124 AML cases (Appendix Table S5).